| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Circulation, Vol 68, 1006-1012, Copyright © 1983 by American Heart Association
M Sederholm, P Grottum, L Erhardt and J Kjekshus
The accuracy of the use of the maximal QRS vector difference to estimate
myocardial infarct size irrespective of infarct location was compared with
that of measurement of cumulative creatine kinase (CK) release. Sixty
patients with acute myocardial infarction and a history of symptoms of less
than 4 hr duration were followed for 24 to 72 hr with orthogonal
vectorcardiography and CK release analysis. Spatial QRS vector differences
were calculated between the first QRS complex recorded and subsequent QRS
complexes at timed intervals. The QRS vector difference increased rapidly
and reached a plateau at an average 12.1 hr after onset of symptoms, as
compared with 34.0 hr for the cumulated CK release. In 42% of the patients
a stepwise progression of infarct evolution was observed. Irrespective of
infarct location the maximal spatial ST vector magnitude was related to the
ultimate QRS vector difference (r = .80) and to the cumulative amount of CK
released (r = .64). Furthermore, maximal QRS vector difference correlated
well with the maximal cumulative CK release (r = .64) Ten patients had
possible infarct expansion, as indicated by recurrent QRS changes without
concomitant CK release. Fifteen patients had infarct extension that was
indicated by secondary CK release and that in seven patients was associated
with further QRS changes. Infarct extension caused an approximate 25%
increase in infarct size. Spatial ST vector magnitude, QRS vector
difference, and cumulative CK release are complementary measures in the
quantification of evolving myocardial injury after acute coronary occlusion
and in the determination of sequels to therapeutic interventions.
ARTICLES
Quantitative assessment of myocardial ischemia and necrosis by continuous vectorcardiography and measurement of creatine kinase release in patients
This article has been cited by other articles:
![]() |
E. Camenzind, P.-P. Kint, C. Di Mario, J. Ligthart, W. van der Giessen, E. Boersma, and P. W. Serruys Intracoronary Heparin Delivery in Humans : Acute Feasibility and Long-term Results Circulation, November 1, 1995; 92(9): 2463 - 2472. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1983 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |